These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 212815)

  • 1. [Studies of resumption of treatment with rifampin and ethambutol in patients with recurrent pulmonary tuberculosis].
    Jozefovics F; Barbu Z; Bálinth E; Ovári AM
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1978; 27(3):177-84. PubMed ID: 212815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effectivity of intermittent RMP/EMB treatment in patients with chronic pulmonary tuberculosis (author's transl)].
    Frenzel I; Neumeyer D
    Z Erkr Atmungsorgane; 1976 Aug; 146(2):145-52. PubMed ID: 1020361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of new and chronic tuberculous patients with ethambutol and Rifampicin (author's transl)].
    Pregowski W; Stanczuk A; Znaniecka H; Cesarz-Fronczyk M
    Z Erkr Atmungsorgane; 1976 May; 145(2):220-6. PubMed ID: 983179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
    Engbaek HC; Heckscher T; Højgaard C; Larsen SO; Rasmussen KN; Vergmann B
    Eur J Respir Dis; 1982 Mar; 63(2):84-93. PubMed ID: 7040100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic drug-resistant pulmonary tuberculosis with rifampin and ethambutol.
    Jeanes CW; Jessamine AG; Eidus L
    Can Med Assoc J; 1972 Apr; 106(8):884-8. PubMed ID: 4623743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rifampicin combined with ethambutol and other antitubercular drugs in the treatment of patients with pulmonary tuberculosis. Early results. I. Bacteriological evaluation].
    Masztalerz J
    Pneumonol Pol; 1976; 44(1):55-60. PubMed ID: 821043
    [No Abstract]   [Full Text] [Related]  

  • 7. [Long-term results of treatment with rifampicin and ethambutol in hyperchronic pulmonary tuberculosis with polyresistant bacilli].
    Anastasatu C; Sibila S
    Ftiziologia; 1973; 22(5):477-84. PubMed ID: 4751363
    [No Abstract]   [Full Text] [Related]  

  • 8. [Long-term results in a group of patients with chronic pulmonary tuberculosis treated with a regimen of RMP and ETB 2/7].
    Aman A; Nicolau G; Nicolescu M; Pralea T; Sturdza N; Stancu I
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1979; 28(2):115-20. PubMed ID: 227037
    [No Abstract]   [Full Text] [Related]  

  • 9. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intermittent chemotherapy from the beginning or only after a period of daily administration? Quantitative bacteriological study at the initial phase of chemotherapy with INH + RMP + EMB in daily or intermittent administration].
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1977; 26(4):193-205. PubMed ID: 204971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC; Lee YC
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
    Wang JY; Lee LN; Yu CJ; Chien YJ; Yang PC;
    Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of rifampin and ethambutol in the treatment of pulmonary tuberculosis].
    Gol'dshteĭn VD; Prokhorov EP
    Probl Tuberk; 1973; 51(12):36-40. PubMed ID: 4782101
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of chronic pulmonary tuberculosis with rifampin and ethambutol by the continuous and intermittent methods].
    Kotowska M; Zelski S
    Gruzlica; 1974 May; 42(5):417-9. PubMed ID: 4464230
    [No Abstract]   [Full Text] [Related]  

  • 18. [ rpceedomgs" Intermittent 2-phase regimen in therapy of chronic pulmonary tuberculosis].
    Zierski M
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):116-23. PubMed ID: 4491708
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rifampicin and ethanbutol in daily and intermittent treatment of chronic advanced cavernous pulmonary tuberculosis resistant to many drugs. Preliminary communication. Early results].
    Zierski M; Bek E; Kucharska A; Graczyk J; Bukalska Z
    Gruzlica; 1973 Nov; 41(11):1129-37. PubMed ID: 4765793
    [No Abstract]   [Full Text] [Related]  

  • 20. Daily and intermittent short-course regimens in the original treatment of pulmonary tuberculosis. Preliminary results. Cooperative comparative clinical study in Poland.
    Zierski M
    Scand J Respir Dis Suppl; 1978; 102():48-52. PubMed ID: 278215
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.